Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Recent Price Trend in Amer Sports, Inc. (AS) is Your Friend, Here's Why
Recent Price Trend in Amer Sports, Inc. (AS) is Your Friend, Here's Why

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure

AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense
AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense

AbbVie ABBV stock has declined 3.2% in a month. Shares of this large drugmaker dipped recently after it denied takeover talks with Redwood City, CA-based cancer biotech, Revolution Medicines RVMD

Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?
Should You Add These 3 Top-Performing Mutual Funds to Your Portfolio?

It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.

The

3 Oversold Stocks Ready to Rebound in 2026: https://www.marketbeat.com/logos/articles/med_20260109142554_3-oversold-stocks-ready-to-rebound-in-2026.png
3 Oversold Stocks Ready to Rebound in 2026

The S&P 500 booked its third consecutive gain of over 15% in 2025, but it wasn’t a banner year for everyone. Some of the market’s previous objects of affection treaded water in 2025, especially

Synchrony (SYF) is a Top-Ranked Momentum Stock: Should You Buy?
Synchrony (SYF) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why Roku (ROKU) is a Top Momentum Stock for the Long-Term
Why Roku (ROKU) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Invesco (IVZ) is a Top-Ranked Momentum Stock: Should You Buy?
Invesco (IVZ) is a Top-Ranked Momentum Stock: Should You Buy?

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Fifth Third Bancorp (FITB) is a Strong Momentum Stock
Here's Why Fifth Third Bancorp (FITB) is a Strong Momentum Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Standard Motor Products (SMP) is a Strong Growth Stock
Here's Why Standard Motor Products (SMP) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Why GSK (GSK) is a Top Growth Stock for the Long-Term
Why GSK (GSK) is a Top Growth Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Eli Lilly (LLY) is a Strong Growth Stock
Here's Why Eli Lilly (LLY) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Haemonetics (HAE) is a Strong Growth Stock
Here's Why Haemonetics (HAE) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Central Garden (CENT) is a Strong Growth Stock
Here's Why Central Garden (CENT) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why BJ's Wholesale Club (BJ) is a Strong Growth Stock
Here's Why BJ's Wholesale Club (BJ) is a Strong Growth Stock

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Are Business Services Stocks Lagging  Agora (API) This Year?
Are Business Services Stocks Lagging Agora (API) This Year?

For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Agora, Inc. Sponsored ADR (API) been one of

Why BorgWarner (BWA) is a Top Value Stock for the Long-Term
Why BorgWarner (BWA) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround

A downtrend has been apparent in Aquestive Therapeutics (AQST) lately with too much selling pressure. The stock has declined 37% over the past four weeks. However, given the fact that it is now in

Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)

AngioDynamics (ANGO) has been on a downward spiral lately with significant selling pressure. After declining 25% over the past four weeks, the stock looks well positioned for a trend reversal as it

INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced

Shares of Insmed INSM gained more than 3% on Friday after the company reported preliminary sales numbers for full-year 2025. It also outlined some expected milestones related to its commercial